FDA warns of recalled compounded drugs in Michigan

The Food and Drug Administration is warning doctors, veterinarians and patients to avoid certain sterile drugs distributed by the Specialty Medicine Compounding Pharmacy of Michigan.

The pharmacy, in South Lyon near Detroit, has recalled drugs distributed in Michigan between July 1 and Oct. 19. The company says no drugs were distributed outside the state.

The specialty pharmacy agreed to conduct the recall after finding floating particles in a sterile that came from a lot that may have been given to hospital patients. The FDA says it's unclear what the particles were.

The FDA recommends doctors and stop using drugs from the pharmacy immediately. For additional details, the public can contact the Specialty Medicine Compounding Pharmacy at 248-446-2643.

No have been reported in connection with the recall.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA: Georgia pharmacy recalling all sterile drugs

Mar 21, 2013

(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.

Indianapolis pharmacy recalls compounded drugs

Apr 23, 2013

(AP)—A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.

Fla. compounding pharmacy recalls sterile drugs

Apr 21, 2013

A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria.

US warns of mold in recalled specialty drugs

Mar 18, 2013

The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.

Recommended for you

Supercomputers link proteins to drug side effects

2 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

9 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments